Renalytix Plc (RNLXY)
4.00
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Renalytix Max Drawdown (5Y) : 99.87% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.87% |
| August 31, 2026 | 99.87% |
| July 31, 2026 | 99.87% |
| June 30, 2026 | 99.87% |
| May 31, 2026 | 99.87% |
| April 30, 2026 | 99.87% |
| March 31, 2026 | 99.85% |
| February 28, 2026 | 99.71% |
| January 31, 2026 | 99.62% |
| December 31, 2025 | 99.62% |
| November 30, 2025 | 99.62% |
| October 31, 2025 | 99.62% |
| September 30, 2025 | 99.62% |
| August 31, 2025 | 99.62% |
| July 31, 2025 | 99.62% |
| June 30, 2025 | 99.62% |
| May 31, 2025 | 99.62% |
| April 30, 2025 | 99.62% |
| March 31, 2025 | 99.62% |
| February 28, 2025 | 99.62% |
| January 31, 2025 | 99.62% |
| December 31, 2024 | 99.62% |
| November 30, 2024 | 99.61% |
| October 31, 2024 | 99.58% |
| September 30, 2024 | 99.40% |
| Date | Value |
|---|---|
| August 31, 2024 | 99.34% |
| July 31, 2024 | 99.34% |
| June 30, 2024 | 99.34% |
| May 31, 2024 | 99.25% |
| April 30, 2024 | 99.25% |
| March 31, 2024 | 99.25% |
| February 29, 2024 | 99.25% |
| January 31, 2024 | 99.25% |
| December 31, 2023 | 99.05% |
| November 30, 2023 | 98.63% |
| October 31, 2023 | 97.01% |
| September 30, 2023 | 96.95% |
| August 31, 2023 | 96.95% |
| July 31, 2023 | 96.95% |
| June 30, 2023 | 96.95% |
| May 31, 2023 | 96.95% |
| April 30, 2023 | 96.95% |
| March 31, 2023 | 96.95% |
| February 28, 2023 | 96.95% |
| January 31, 2023 | 96.95% |
| December 31, 2022 | 96.95% |
| November 30, 2022 | 96.95% |
| October 31, 2022 | 96.95% |
| September 30, 2022 | 96.32% |
| August 31, 2022 | 94.02% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| CompuMed, Inc. | 85.00% |
| Quest Diagnostics, Inc. | 28.60% |
| Labcorp Holdings, Inc. | 34.60% |
| Myriad Genetics, Inc. | 92.20% |
| OPKO Health, Inc. | 85.55% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -92.71 |
| Beta (5Y) | 2.655 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 150.8% |
| Historical Sharpe Ratio (5Y) | -0.4386 |
| Historical Sortino (5Y) | -1.304 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 44.92% |